Introduction: Quilombola women in the Amazon face social, cultural and geographic barriers to accessing health care. Analyzing the estimated risk of cancer in this population can contribute to more effective and culturally sensitive prevention strategies.. Objectives:To describe the estimated cancer risk profile among women from a quilombola community in Baixo Tocantins, Pará, through the application of the Q-Cancer questionnaire. Methods: Descriptive, population-based study conducted with 13 women living in a quilombola community in Baixo Tocantins (PA). The Q-Cancer questionnaire was used, which estimates individual risk for various types of cancer based on sociodemographic and clinical data. The variables analyzed included age, smoking, alcohol consumption, family history of cancer, and estimated risk for 13 types of cancer. Data were analyzed descriptively using mean, standard deviation, and proportions. The study was approved by the Research Ethics Committee of ITPAC Porto Nacional, under CAAE 85751624.3.0000.8075. Results: The mean age was 36.6 years (±13.1). Only 1 (7.7%) participant reported smoking and none reported drinking alcohol. Three women (23.1%) had a family history of cancer. The estimated overall mean risk of cancer was 12.6% (±25.1%). The highest estimated mean risks were for colorectal cancer (2.6%), breast cancer (1.8%), and cancers classified as “other” (2.1%). Smaller but present risks were identified for cervical (0.3%), ovarian (0.3%), uterine (0.4%), and kidney (0.2%) cancers. No significant risks were identified for lung, pancreatic, hematologic, or gastroesophageal cancers. Conclusion: Quilombola women from the Lower Tocantins region presented a significant estimated risk for female neoplasms, such as breast, cervical, ovarian and uterine cancer, in addition to a significant risk for colorectal cancer. Low alcohol and tobacco consumption may reflect protective practices, although the presence of oncological risk reinforces the importance of public policies aimed at early screening and health promotion in traditional communities in the Amazon.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
